Aquestive Therapeutics Q3 EPS $(0.74) Misses $(0.69) Estimate, Sales $12.418M Beat $9.97M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.69) by 7.25 percent. The company reported quarterly sales of $12.418 million which

Benzinga · 11/05/2019 22:03

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.69) by 7.25 percent. The company reported quarterly sales of $12.418 million which beat the analyst consensus estimate of $9.97 million by 24.55 percent.